EG:NYSEEverest Group, Ltd. Analysis
Data as of 2026-08-31 - not real-time
$374.65
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Everest Group, Ltd. trades at $374.65, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has lost 1.1% over the past 30 days. With RSI at 52.7 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $360.63 and resistance at $381.99.
The shares look undervalued, trading on 7.9 times earnings below a sector average of 16.9. Consensus targets land 9.0% above where the shares trade now. Revenue is contracting at 11.3% on a 11.4% profit margin. The 2.12% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 22.7%, a beta of -0.01 and a maximum drawdown of 16.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.
The shares look undervalued, trading on 7.9 times earnings below a sector average of 16.9. Consensus targets land 9.0% above where the shares trade now. Revenue is contracting at 11.3% on a 11.4% profit margin. The 2.12% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 22.7%, a beta of -0.01 and a maximum drawdown of 16.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.
Top Market Events
Looking back on reinsurance stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including...Global reinsurance company Everest Group NYSE:EG in Q2 CY2026, with sales falling 11.Investment management company Vulcan Value Partners recently released its second-quarter 2026 investor letter.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 341.71
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 7.9 versus sector average of 16.9
- Trading above the 200-day average of 341.71
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 7.9 versus sector average of 16.9
- Analyst targets imply +9.0% versus the current price
- Revenue contracting at -11.3%
Key Metrics & Analysis
Financial Health
Revenue Growth-11.30%
Profit Margin11.38%
P/E Ratio7.9
ROE12.57%
ROA2.49%
Debt/Equity23.26
P/B Ratio0.9
Op. Cash Flow$2.0B
Free Cash Flow$2.1B
Industry P/E16.9
Technical Analysis
TrendBullish
RSI52.7
Support$360.63
Resistance$381.99
MA 20$371.00
MA 50$370.37
MA 200$341.71
MACDBullish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$686.21
Target Price$408.47
Upside/Downside9.03%
GradeUndervalued
TypeValue
Dividend Yield2.12%
Risk Assessment
Beta-0.01
Volatility22.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.